All Pharma articles – Page 41
-
NewsIan Kennedy report looks at how NICE values innovation
The benefits to the NHS of innovative health technologies are being weighed by the National Institute for Health and Clinical Excellence after a study by Sir Ian Kennedy.
-
HSJ KnowledgePowerful chemistry: PCTs under fire for not aiding pharmacy growth
Pharmacists have the potential to deliver a far wider range of services than at present - but the opportunity will be missed if primary care trusts do not act, writes Graham Clews
-
LeaderPatients don't care who provides GP services as long as they work
Why does the public have to endure antiquated GP services?
-
NewsFast track drugs fears for NHS budget
Unregulated pharmaceuticals may be allowed to inflate the NHS drugs bill for little benefit to patients according to independent health policy analyst Roy Lilley.
-
NewsCMO reassures over supplies of Tamiflu
The government’s chief medical officer has said that Britain has enough Tamiflu after it was revealed that the number of new swine flu cases could hit 100,000 per day.
-
NewsGovernment abandons swine flu containment efforts
The prevalence of swine flu in some parts of the country means that the government is abandoning attempts to contain the virus and is instead moving towards a policy of outbreak management.
-
CommentSophia Christie on NICE and lifesaving myths
Last year, journalist Adam Wishart approached me about taking part in a television documentary, The Price of Life, which aired on BBC2 last week.
-
NewsNHS prescription review delayed until autumn
The health minister has said a delayed review into the costs of prescriptions will be published in the autumn.
-
CommentPhilip DaSilva on preparing for a pandemic
Last week the WHO declared a flu pandemic. Preparedness must now become a top priority for boards rather than treating it as part of the annual winter planning routine
-
NewsCalls for NHS to fund costly drugs 'blinkered', says NICE
A senior member of the UK’s drugs watchdog has labelled people who demand expensive drugs on the NHS as “blinkered”.
-
NewsFears grow over flu pandemic stockpiles
Concerns are growing over whether primary care trusts will be able to avoid running out of flu pandemic equipment amid confusion over who should be stockpiling supplies.
-
NewsNHS nets huge drugs saving
The NHS has saved nearly £400m in the space of a year through more cost effective prescribing.
-
NewsMPs warn NICE over cancer drug 'inequities'
MPs have attacked as “inequitable and inefficient” the decision by the National Institute for Health and Clinical Excellence to allow less cost efficient drugs to be given to people at the end of their lives.
-
NewsSwine flu stockpiles could compromise NHS, pharmacists warned
The Department of Health has warned pharmacists not to stockpile swine flu medicines because this could undermine the NHS’s ability to cope with a pandemic.
-
NewsSwine flu fears increase as WHO ups alert level for second time
The World Health Organisation has raised its pandemic flu alert level for the second time in the space of a week, increasing fears that a global outbreak is inevitable.
-
CommentMedia Watch: swine flu
The Department of Health was quick to offer reassurance at the start of this week after warnings of a pandemic of a new killer flu virus.
-
NewsWHO raises alert level as UK swine flu cases confirmed
The World Health Organisation has raised its threat level to indicate increased risk of a flu pandemic in the wake of confirmed swine flu cases in several countries.
-
NewsAlan Johnson: UK among best prepared for swine flu outbreak
Health secretary Alan Johnson has attempted to calm fears over an outbreak of a new strain of flu called swine influenza.
-
News
Budget 2009: ABPI welcomes tax review proposal
The pharmaceutical industry has welcomed plans in the Budget to consider changes that could make the tax system more favourable to research and innovation.
-
HSJ KnowledgeHow PCTs can involve the public in funding decisions
The public may still be reticent about getting involved in decision making about drug and treatment funding but PCTs are expected to engage them. Lynne Greenwood reports